Elanco Animal Health Incorporated Costs and Expenses
Elanco Animal Health Incorporated (ELAN) reported Costs and Expenses of $3.95 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2025-02-25
- Elanco Animal Health Incorporated costs and expenses for the quarter ending 2024-12-31 was $1.07B, a 7.83% decline year-over-year.
- Elanco Animal Health Incorporated costs and expenses for the quarter ending 2024-09-30 was $471.00M, a 78.24% decline year-over-year.
- Elanco Animal Health Incorporated costs and expenses for the quarter ending 2024-06-30 was $1.22B, a 7.04% increase year-over-year.
- Elanco Animal Health Incorporated costs and expenses for the quarter ending 2024-03-31 was $1.19B, a 3.83% increase year-over-year.
- Elanco Animal Health Incorporated costs and expenses for fiscal 2024 was $3.95B, a 29.60% decline from fiscal 2023.
- Elanco Animal Health Incorporated costs and expenses for fiscal 2023 was $5.61B, a 25.18% increase from fiscal 2022.
- Elanco Animal Health Incorporated costs and expenses for fiscal 2022 was $4.48B, a 15.97% decline from fiscal 2021.
- Elanco Animal Health Incorporated costs and expenses for fiscal 2021 was $5.33B, a 35.13% increase from fiscal 2020.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.54B derived: sum of 2 quarters · filed 2025-02-25 | $2.76B derived: sum of 3 quarters · filed 2025-02-25 | $3.95B 10-K · filed 2025-02-25 | ||||
| 2024-09-30 | $471.00M 10-Q · filed 2024-11-07 | $1.69B derived: sum of 2 quarters · filed 2024-11-07 | $2.88B 10-Q · filed 2024-11-07 | $4.04B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2024-06-30 | $1.22B 10-Q · filed 2024-08-08 | $2.41B 10-Q · filed 2024-08-08 | $3.57B derived: sum of 3 quarters · filed 2025-02-25 | $5.74B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2024-03-31 | $1.19B 10-Q · filed 2024-05-08 | $2.35B derived: sum of 2 quarters · filed 2025-02-25 | $4.52B derived: sum of 3 quarters · filed 2025-02-25 | $5.66B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-12-31 | $1.16B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.33B derived: sum of 2 quarters · filed 2025-02-25 | $4.46B derived: sum of 3 quarters · filed 2025-02-25 | $5.61B 10-K · filed 2025-02-25 | ||||
| 2023-09-30 | $2.17B 10-Q · filed 2024-11-07 | $3.30B derived: sum of 2 quarters · filed 2024-11-07 | $4.45B 10-Q · filed 2024-11-07 | $5.52B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $1.14B 10-Q · filed 2024-08-08 | $2.29B 10-Q · filed 2024-08-08 | $3.36B derived: sum of 3 quarters · filed 2025-02-25 | $4.43B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $1.15B 10-Q · filed 2024-05-08 | $2.22B derived: sum of 2 quarters · filed 2025-02-25 | $3.29B derived: sum of 3 quarters · filed 2025-02-25 | $4.48B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.14B derived: sum of 2 quarters · filed 2025-02-25 | $3.33B derived: sum of 3 quarters · filed 2025-02-25 | $4.48B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $1.07B 10-Q · filed 2023-11-07 | $2.26B derived: sum of 2 quarters · filed 2023-11-07 | $3.41B 10-Q · filed 2023-11-07 | $3.42B 10-Q · filed 2022-11-08 | $4.65B derived: sum of 4 quarters · filed 2024-02-26 | |||
| 2022-06-30 | $1.19B 10-Q · filed 2023-08-07 | $1.20B 10-Q · filed 2022-08-08 | $2.34B 10-Q · filed 2023-08-07 | $2.35B 10-Q · filed 2022-08-08 | $3.58B derived: sum of 3 quarters · filed 2024-02-26 | $4.84B derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2022-03-31 | $1.15B 10-Q · filed 2023-05-09 | $1.15B 10-Q · filed 2022-05-09 | $2.39B derived: sum of 2 quarters · filed 2024-02-26 | $3.65B derived: sum of 3 quarters · filed 2024-02-26 | $5.16B derived: sum of 4 quarters · filed 2024-02-26 | |||
| 2021-12-31 | $1.24B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $2.50B derived: sum of 2 quarters · filed 2024-02-26 | $4.01B derived: sum of 3 quarters · filed 2024-02-26 | $5.33B 10-K · filed 2024-02-26 | $5.33B 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $1.26B 10-Q · filed 2022-11-08 | $2.78B derived: sum of 2 quarters · filed 2022-11-08 | $4.10B 10-Q · filed 2022-11-08 | $5.56B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $1.51B 10-Q · filed 2022-08-08 | $2.84B 10-Q · filed 2022-08-08 | $4.30B derived: sum of 3 quarters · filed 2023-03-01 | $5.40B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $1.32B 10-Q · filed 2022-05-09 | $2.78B derived: sum of 2 quarters · filed 2023-03-01 | $3.88B derived: sum of 3 quarters · filed 2023-03-01 | $4.54B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.56B derived: sum of 2 quarters · filed 2023-03-01 | $3.22B derived: sum of 3 quarters · filed 2023-03-01 | $3.95B 10-K · filed 2023-03-01 | $3.95B 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $1.10B 10-Q · filed 2021-11-05 | $1.10B 10-Q · filed 2020-11-06 | $1.76B derived: sum of 2 quarters · filed 2021-11-05 | $2.49B 10-Q · filed 2021-11-05 | $2.49B 10-Q · filed 2020-11-06 | $3.28B derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $663.00M 10-Q · filed 2021-08-09 | $663.40M 10-Q · filed 2020-07-30 | $1.39B 10-Q · filed 2021-08-09 | $1.39B 10-Q · filed 2020-07-30 | $2.18B derived: sum of 3 quarters · filed 2022-02-28 | $2.96B derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $726.00M 10-Q · filed 2021-05-07 | $725.50M 10-Q · filed 2020-05-07 | $1.52B derived: sum of 2 quarters · filed 2022-02-28 | $2.30B derived: sum of 3 quarters · filed 2022-02-28 | $3.03B derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $791.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.58B derived: sum of 2 quarters · filed 2022-02-28 | $2.31B derived: sum of 3 quarters · filed 2022-02-28 | $2.99B 10-K · filed 2022-02-28 | $2.99B 10-K · filed 2020-02-28 | |||
| 2019-09-30 | $783.80M 10-Q · filed 2020-11-06 | $1.52B derived: sum of 2 quarters · filed 2020-11-06 | $2.20B 10-Q · filed 2020-11-06 | $3.00B derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $731.40M 10-Q · filed 2020-07-30 | $1.42B 10-Q · filed 2020-07-30 | $2.22B derived: sum of 3 quarters · filed 2021-03-01 | $2.90B derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $686.30M 10-Q · filed 2020-05-07 | $1.49B derived: sum of 2 quarters · filed 2021-03-01 | $2.17B derived: sum of 3 quarters · filed 2021-03-01 | $2.98B derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $801.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.48B derived: sum of 2 quarters · filed 2021-03-01 | $2.29B derived: sum of 3 quarters · filed 2021-03-01 | $2.95B 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $682.30M 10-Q · filed 2019-11-08 | $1.49B derived: sum of 2 quarters · filed 2019-11-08 | $2.15B 10-Q · filed 2019-11-08 | $3.06B derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-06-30 | $810.20M 10-Q · filed 2019-08-13 | $1.47B 10-Q · filed 2019-08-13 | $2.38B derived: sum of 3 quarters · filed 2020-02-28 | $3.08B derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-03-31 | $658.70M 10-Q · filed 2019-05-14 | $1.57B derived: sum of 2 quarters · filed 2020-02-28 | $2.27B derived: sum of 3 quarters · filed 2020-02-28 | |||||
| 2017-12-31 | $909.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.62B derived: sum of 2 quarters · filed 2020-02-28 | $3.12B 10-K · filed 2020-02-28 | |||||
| 2017-09-30 | $706.20M 10-Q · filed 2018-11-08 | $2.21B 10-Q · filed 2018-11-08 | ||||||
| 2016-12-31 | $2.94B 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |